These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26058565)

  • 1. Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety.
    Redko B; Ragozin E; Andreii B; Helena T; Amnon A; Talia SZ; Mor OH; Genady K; Gary G
    Biopolymers; 2015 Nov; 104(6):743-52. PubMed ID: 26058565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
    Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
    Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New somatostatin-drug conjugates for effective targeting pancreatic cancer.
    Ragozin E; Hesin A; Bazylevich A; Tuchinsky H; Bovina A; Shekhter Zahavi T; Oron-Herman M; Kostenich G; Firer MA; Rubinek T; Wolf I; Luboshits G; Sherman MY; Gellerman G
    Bioorg Med Chem; 2018 Jul; 26(13):3825-3836. PubMed ID: 30017114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor-targeted anti-cancer therapy.
    Sun LC; Coy DH
    Curr Drug Deliv; 2011 Jan; 8(1):2-10. PubMed ID: 21034425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin analogs and radiopeptides in cancer therapy.
    Froidevaux S; Eberle AN
    Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of cancer cell lines for peptide receptor-targeted drug development.
    Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
    J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.
    Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
    Biopolymers; 2016 Mar; 106(2):160-171. PubMed ID: 26715008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents.
    Sun L; Fuselier JA; Coy DH
    Drug Deliv; 2004; 11(4):231-8. PubMed ID: 15371104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids.
    Naydenova E; Wesselinova D; Staykova S; Danalev D; Dzimbova T
    Amino Acids; 2019 Sep; 51(9):1247-1257. PubMed ID: 31350614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.
    Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M
    Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.
    Zheng N; Dai W; Du W; Zhang H; Lei L; Zhang H; Wang X; Wang J; Zhang X; Gao J; Zhang Q
    Mol Pharm; 2012 May; 9(5):1175-88. PubMed ID: 22435704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in vitro stability and cytostatic effect of multifunctional anticancer drug-bioconjugates containing GnRH-III as a targeting moiety.
    Leurs U; Mező G; Orbán E; Öhlschläger P; Marquardt A; Manea M
    Biopolymers; 2012; 98(1):1-10. PubMed ID: 21509746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.
    Sun L; Morris LM; Luo J; Mackey LV; Leslie JS; Franko-Tobin LG; Fuselier JA; LePage KT; Coy DH
    J Drug Target; 2011 Sep; 19(8):666-74. PubMed ID: 21083509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
    Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
    Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.
    Gaviglio L; Gross A; Metzler-Nolte N; Ravera M
    Metallomics; 2012 Mar; 4(3):260-6. PubMed ID: 22310724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.
    Gilad Y; Firer MA; Rozovsky A; Ragozin E; Redko B; Albeck A; Gellerman G
    Eur J Med Chem; 2014 Oct; 85():139-46. PubMed ID: 25084142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
    Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
    Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L
    Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.